Skip to content

Chartis Console G3

by Pulmonx Corporation

Chartis Console G3 (CHR-CO-100) is a Class II device made by Pulmonx Corporation, cleared under FDA 510(k) K111764 on 10 Nov 2011 and listed in FDA GUDID since 25 Mar 2016 (UDI-DI M776CHRCO100), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K111764

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberM776CHRCO100 UDI-DI Date25 Mar 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK111764 Date10 Nov 2011DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K111764 decided 10 Nov 2011 Active
  • FDA GUDID UDI-DI M776CHRCO100 listed 25 Mar 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K111764
  2. Listed FDA GUDID M776CHRCO100

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Chartis Console
Generic name
Diagnostic spirometer, professional
Model / Ref / Catalog
G3, CHR-CO-100
Primary DI / UDI-DI
M776CHRCO100
510(k) Number
FDA product code
BZG
GMDN term
Diagnostic spirometer, professional
Device class
Class II
Regulation number
868.1840
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Diagnostic spirometer, professional.

Other devices from Pulmonx Corporation

See all devices from Pulmonx Corporation →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)